PREVALENCE OF DIABETES MELLITUS IN PATIENTS WITH CANCER AND COMPARE WITH THE GENERAL PREVALENCE OF THE DIABETES MELLITUS IN TURKISH SOCIETY: RESEARCH ARTICLE

Serdar Olt*, Meltem Baykara, Hasan Ergenç, Selçuk Yaylac? and Ali Tamer

ABSTRACT

Herein our aim was to investigate prevalence of diabetes Mellitus (DM) in patients with cancer and compare with the general prevalence of the DM in Turkish society based on the TURDEP 2 study. Records of 1252 patients were analyzed retrospectively between the years 2010 and 2012. Patients' cancer type, age, gender and presence of diabetes were recorded. Mean age of the patients was 63. 680 (54.3%) of the patients were female and 572 (45.7%) were male. The DM prevalence was 13.3% in all patients with cancer. According to the types of cancer the prevalence of the DM was: 14.8% in Breast cancer, 13.1% in Lung cancer, 9.7% in Colon cancer, 7.4% Rectum cancer, 11.7% Gastric cancer, 23.6% Ovary cancer, %30 Endometrium cancer, 12.5% Prostate cancer and 10.5% Pancreas cancer respectively. Prevalence of DM was detected 16.5% in TURDEP 2 study in general Turkish society recently. Considering the general prevalence of DM in Turkey, we found that the DM rates in our patients with cancer are lower than this rate. Although there is a relationship between some types of cancer and DM in the literature, this issue is subject to debate, and further studies are needed in this area.

Keywords: Cancer, Diabetes mellitus, TURDEP 2 study.